Investor Relations

Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research. The Company has developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry and optics, Pacific Biosciences has created a powerful technology platform called single molecule, real-time, or SMRT™, technology. SMRT technology enables real-time analysis of biomolecules with single molecule resolution, which has the potential to transform the understanding of biological systems by providing a window into these systems that has not previously been open for scientific study.

Featured Event

May 5, 2015 at 4:30 PM ET
Pacific Biosciences of California, Inc. First Quarter 2015 Earnings Conference Call

Recent News

May 5, 2015
Pacific Biosciences Achieves Second Development Milestone in Clinical Diagnostics Agreement With Roche

MENLO PARK, Calif., May 5, 2015 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), provider of the PacBio® RS II Sequencing System, today announced that it has achieved a ...


May 5, 2015
Pacific Biosciences of California, Inc. Announces First Quarter 2015 Financial Results

MENLO PARK, Calif., May 5, 2015 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) today reported a 52% increase in revenue with $17.6 million for the first quarter ended March ...


Stock Quote

NASDAQ (GM) : PACB
Price
$5.46
Last Trade
4:00 PM ET
May 28, 2015
Change
$-0.13
Change (%)
-2.326%
Volume
706,000
52 Week High
8.78
52 Week Low
4.38
Day High
5.61
Day Low
5.30

Investor
Contacts

Pacific Biosciences

1380 Willow Rd.
Menlo Park, CA 94025
(650) 521-8450
ir@pacificbiosciences.com

Supernav grey background

Supernav grey background

Super Navigation block